Infectious Disease Therapeutics Market Scope And Analysis

  • Report Code : TIPRE00016883
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 193
Buy Now

Infectious Diasease Therapeutics Market Scope and Analysis by 2031

Buy Now


Infectious Disease Therapeutics Market Report Scope

Report Attribute Details
Market size in 2022 US$ 1,19,708.77 Million
Market Size by 2030 US$ 1,67,883.93 Million
Global CAGR (2022 - 2030) 4.3%
Historical Data 2020-2021
Forecast period 2022-2030
Segments Covered By Drug Class
  • Anti-viral
  • Anti Bacterial
  • Anti-Fungal
By Indication
  • HIV
  • Hepatitis
  • Tuberculosis
  • Influenza
  • HPV
By Route of Administration
  • Oral
  • Parenteral
  • Topical
By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Pfizer Inc
  • Gilead Sciences Inc
  • F Hoffmann La Roche Ltd
  • Shionogi Co Ltd
  • Bayer AG
  • BioCryst Pharmaceuticals Inc
  • GSK Plc
  • AbbVie Inc
  • Merck Co Inc
  • Astellas Pharma Inc
  • Infectious Disease Therapeutics Market News and Recent Developments

    The infectious disease therapeutics market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the infectious disease therapeutics market are listed below:

    • Roche launched the first infectious disease tests and cobas omni–Utility Channel for use on the cobas 5800 System in countries accepting the CE Mark. The cobas omni–Utility Channel on the cobas 5800 System enables a broader testing menu by consolidating open channel assays with Roche in vitro diagnostic (IVD) assays on a single platform. (Source: F. Hoffmann-La Roche Ltd, Press Release, December 2022)

    Infectious Disease Therapeutics Market Report Coverage and Deliverables

    The “Infectious Disease Therapeutics Market Size and Forecast (2020–2030)” report provides a detailed analysis of the market covering below areas:

    • Infectious disease therapeutics market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
    • Infectious disease therapeutics market trends as well as market dynamics such as drivers, restraints, and key opportunities
    • Detailed PEST/Porter’s Five Forces and SWOT analysis
    • infectious disease therapeutics market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
    • Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the infectious disease therapeutics market
    • Detailed company profiles